ABSTRACT
Purpose
Methods
Results
Conclusions
Keywords
REFERENCES
- Cancer F acts & F igures .American Cancer Society, Atlanta, GA2018: 2018
- The meaning of cancer: Implications for family finances and consequent impact on lifestyle, activities, roles and relationships.Psychooncology. 2012; 21: 1167-1174
- Cancer F acts & F igures 2008 S pecial S ection: Insurance and C ost- R elated B arriers to C ancer C are .American Cancer Society, Atlanta, GA2008
- National estimates of medical costs incurred by nonelderly cancer patients.Cancer. 2004; 100: 883-891
- Cancer survivors and unemployment: a meta-analysis and meta-regression.JAMA. 2009; 301: 753-762
- The financial burden of cancer: estimates from a study of insured women with breast cancer.J Support Oncol. 2004; 2: 271-278
- Financial toxicity, Part I: a new name for a growing problem.Oncology. 2013; 27: 80-81
- The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment.Ca Cancer J Clin. 2018; 68: 153-165
- Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received.J Clin Oncol. 2016; 34: 2925-2934
- RAND HRS D ata D ocumentation (Version K). Santa Monica, CA.RAND Center for the Study of Aging. 2011;
- Technical D escription of the H ealth and R etirement S tudy S urvey S ample Designs (No. 1). Ann Arbor.MI: University of Michigan Survey Research Center. 1995;
- (Available at:) (Accessed May 5])
- Revisiting the behavioral model and access to medical care: Does it matter?.J Health Soc Behav. 1995; 36: 1-C
- Inequality in income and mortality in the United States: analysis of mortality and potential pathways.Brit Med J. 1996; 312: 999-1003
- The life cycle hypothesis of saving, the demand for wealth and the supply of capital.Soc Res. 1966; 33: 160-217
- Econometric approaches in evaluating costs and outcomes within pharmacoeconomic analyses.Pharm Policy Law. 2012; 14: 105-122
- Medical bankruptcy in the United States, 2007: Results of a national study.Am J Med. 2009; 122: 741-746
- Washington state cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis.Health Aff. 2013; 6: 1143-1152
- Estimating health care costs related to cancer treatment from SEER-Medicare data.Med Care. 2002; 40: 104-117
- Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.Med Care. 1995; 33: 828-841
- Cost of care for elderly cancer patients in the United States.J Ntl Cancer Inst. 2008; 100: 630-641
- Comparison of approaches for estimating prevalence costs of care for cancer patients: What is the impact of data source?.Med Care. 2009; 47: s64-69
- Polypharmacy and patterns of prescription medication use among cancer survivors.Cancer. 2018; : 1-8
- Economic burden of cancer in the United States: estimates, projections, and future research.Cancer Epidemiol Biomarkers Prev. 2011; 20: 2006-2014
- Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors.J Cancer Surviv. 2018; 12: 306-315
- The Cancer Atlas .American Cancer Society, 2017 (Available at:) (Accessed June 14)
- Health care expenditures, hospitalizations, and productivity associated with cancer in US employer settings.J Occup Environ Med. 2012; 54: 1453-1460
- Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia.J Clin Oncol. 2014; 32: 306-311
- Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.J Clin Oncol. 2010; 28: 4120-4128
- Nonadherence to imatinib during an economic downturn.N Engl J Med. 2010; 363: 596-598
- Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer.Breast Cancer Res Treat. 2011; 125: 191-200
- Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis .National Academies Press, Washington, DC2013
- Forgoing medical care because of cost: Assessing disparities in healthcare access among cancer survivors living in the United States.Cancer. 2010; 116: 3493-3504
- National survey of households affected by cancer .Kaiser Family Foundation, Washington, DC2006
- Economic burden of cancer survivorship among adults in the United States.J Clin Oncol. 2013; 31: 3749-3757
- Financial insolvency as a risk factor for early mortality among patients with cancer.J Clin Oncol. 2016; 34: 980-986
- Association of negative wealth shock with all-cause mortality in middle-aged and older adults in the United States.JAMA. 2018; 319: 1341-1350
- The Great Recession and the social safety net.Ann Am Acad Pol Soc Sci. 2013; 650: 143-166
- Wealth as security: growth curve analyses of household income and net worth during a recession.J Fam Econ Issues. 2016; 37: 29-41
- Changes in E conomic W ell- B eing of the E lderly. New York, NY: City University of New York (CUNY).Academic Works. 2015;
- Household debt and financial assets: Evidence from Germany, Great Britain, and the USA.J R Stat Soc Ser A Stat Soc. 2008; 171: 615-643
- Work and financial disparities among adult cancer survivors in the United States.J Clin Oncol. 2014; 32: 31s
- Out-of-pocket spending and financial burden among Medicare beneficiaries with cancer.JAMA Oncol. 2017; 3: 757-765
- There is a mismatch between the Medicare benefit package and the preferences of patients with cancer and their caregivers.J Clin Oncol. 2014; 32: 3163-3168
- Core elements of the Patient Protection and Affordable Care Act and their relevance to the delivery of high-quality cancer care.Am Soc Clin Oncol Educ Book. 2012; : e4-e8
- From Cancer Patient to Cancer Survivor: Lost in Transition .The National Academies Press, Washington, DC2005
- Distress management. Clinical practice guidelines.J Natl Compr Canc Netw. 2003; 1: 344
- Trends in health care utilization among adults with serious psychological distress: 2003-2014.Psychiatr Serv. 2016; 67: 743-748
- Trends in antidepressant use among US cancer survivors, 1999-2012.Psychiatr Serv. 2015; 66: 564
Article Info
Publication History
Footnotes
Funding: None.
Conflict of Interest: AMG was an employee of Truven Health Analytics, an IBM Company at the time of submission of this work and is currently an employee of Vector Oncology, a Concerto HealthAI company. This work derives, in part, as an extension of AMG's PhD dissertation, completed at The University of Arizona.
Authorship: This endeavor represents original work which has not been previously published or presented and is not under consideration for publication elsewhere. All authors had access to the data and a role in writing the manuscript.

